BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

587 related articles for article (PubMed ID: 12941996)

  • 41. Efficacy of preoperative oral rofecoxib in pain control for third molar surgery.
    Chiu WK; Cheung LK
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2005 Jun; 99(6):e47-53. PubMed ID: 15897845
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Aspirin compared with acetaminophen in the treatment of fever and other symptoms of upper respiratory tract infection in adults: a multicenter, randomized, double-blind, double-dummy, placebo-controlled, parallel-group, single-dose, 6-hour dose-ranging study.
    Bachert C; Chuchalin AG; Eisebitt R; Netayzhenko VZ; Voelker M
    Clin Ther; 2005 Jul; 27(7):993-1003. PubMed ID: 16154478
    [TBL] [Abstract][Full Text] [Related]  

  • 43. A double-blind, placebo controlled comparison of the morphine sparing effect of oral rofecoxib and diclofenac for acute renal colic.
    Engeler DS; Ackermann DK; Osterwalder JJ; Keel A; Schmid HP
    J Urol; 2005 Sep; 174(3):933-6. PubMed ID: 16093996
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Efficacy and tolerability of valdecoxib in treating the signs and symptoms of severe rheumatoid arthritis: a 12-week, multicenter, randomized, double-blind, placebo-controlled study.
    Gibofsky A; Rodrigues J; Fiechtner J; Berger M; Pan S
    Clin Ther; 2007 Jun; 29(6):1071-85. PubMed ID: 17692722
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Preemptive rofecoxib and dexamethasone for prevention of pain and trismus following third molar surgery *.
    Moore PA; Brar P; Smiga ER; Costello BJ
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2005 Feb; 99(2):E1-7. PubMed ID: 15660075
    [TBL] [Abstract][Full Text] [Related]  

  • 46. A randomized, double-blind, placebo-controlled trial of the effects of rofecoxib, a selective cyclooxygenase-2 inhibitor, on rectal polyps in familial adenomatous polyposis patients.
    Higuchi T; Iwama T; Yoshinaga K; Toyooka M; Taketo MM; Sugihara K
    Clin Cancer Res; 2003 Oct; 9(13):4756-60. PubMed ID: 14581346
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Efficacy and safety of lacosamide in diabetic neuropathic pain: an 18-week double-blind placebo-controlled trial of fixed-dose regimens.
    Wymer JP; Simpson J; Sen D; Bongardt S;
    Clin J Pain; 2009 Jun; 25(5):376-85. PubMed ID: 19454870
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Cardiovascular events associated with rofecoxib in a colorectal adenoma chemoprevention trial.
    Bresalier RS; Sandler RS; Quan H; Bolognese JA; Oxenius B; Horgan K; Lines C; Riddell R; Morton D; Lanas A; Konstam MA; Baron JA;
    N Engl J Med; 2005 Mar; 352(11):1092-102. PubMed ID: 15713943
    [TBL] [Abstract][Full Text] [Related]  

  • 49. A 2-week, multicenter, randomized, double-blind, placebo-controlled, dose-ranging, phase III trial comparing the efficacy of oxymorphone extended release and placebo in adults with pain associated with osteoarthritis of the hip or knee.
    Kivitz A; Ma C; Ahdieh H; Galer BS
    Clin Ther; 2006 Mar; 28(3):352-64. PubMed ID: 16750450
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Comparison of the analgesic efficacy of rofecoxib and enteric-coated diclofenac sodium in the treatment of postoperative dental pain: a randomized, placebo-controlled clinical trial.
    Chang DJ; Desjardins PJ; Chen E; Polis AB; McAvoy M; Mockoviak SH; Geba GP
    Clin Ther; 2002 Apr; 24(4):490-503. PubMed ID: 12017395
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Precision of composite measures of osteoarthritis efficacy in comparison to that of individual endpoints.
    Bolognese JA; Ehrich EW; Schnitzer TJ
    J Rheumatol; 2001 Dec; 28(12):2700-4. PubMed ID: 11764220
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Efficacy and safety of the seven-day buprenorphine transdermal system in opioid-naïve patients with moderate to severe chronic low back pain: an enriched, randomized, double-blind, placebo-controlled study.
    Steiner DJ; Sitar S; Wen W; Sawyerr G; Munera C; Ripa SR; Landau C
    J Pain Symptom Manage; 2011 Dec; 42(6):903-17. PubMed ID: 21945130
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Efficacy and safety of lornoxicam compared with placebo and diclofenac in acute sciatica/lumbo-sciatica: an analysis from a randomised, double-blind, multicentre, parallel-group study.
    Herrmann WA; Geertsen MS
    Int J Clin Pract; 2009 Nov; 63(11):1613-21. PubMed ID: 19832818
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Efficacy and safety of rofecoxib 12.5 mg versus nabumetone 1,000 mg in patients with osteoarthritis of the knee: a randomized controlled trial.
    Kivitz AJ; Greenwald MW; Cohen SB; Polis AB; Najarian DK; Dixon ME; Moidel RA; Green JA; Baraf HS; Petruschke RA; Matsumoto AK; Geba GP;
    J Am Geriatr Soc; 2004 May; 52(5):666-74. PubMed ID: 15086644
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Short-term and long-term tolerability of rofecoxib in patients with prior reactions to nonsteroidal anti-inflammatory drugs.
    Nettis E; Colanardi MC; Ferrannini A; Tursi A
    Ann Allergy Asthma Immunol; 2005 Jan; 94(1):29-33. PubMed ID: 15702812
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Maintenance of effect of duloxetine in patients with chronic low back pain: a 41-week uncontrolled, dose-blinded study.
    Skljarevski V; Zhang S; Chappell AS; Walker DJ; Murray I; Backonja M
    Pain Med; 2010 May; 11(5):648-57. PubMed ID: 20546509
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Experience of rofecoxib in patients with osteoarthritis previously treated with traditional non-steroidal anti-inflammatory drugs in Spain: results of phase 2 of the VICOXX study.
    Arboleya LR; de la Figuera E; Soledad García M; Aragón B;
    Curr Med Res Opin; 2003; 19(4):288-97. PubMed ID: 12841921
    [TBL] [Abstract][Full Text] [Related]  

  • 58. A randomized trial of the efficacy and tolerability of the COX-2 inhibitor rofecoxib vs ibuprofen in patients with osteoarthritis. Rofecoxib/Ibuprofen Comparator Study Group.
    Day R; Morrison B; Luza A; Castaneda O; Strusberg A; Nahir M; Helgetveit KB; Kress B; Daniels B; Bolognese J; Krupa D; Seidenberg B; Ehrich E
    Arch Intern Med; 2000 Jun; 160(12):1781-7. PubMed ID: 10871971
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Effect of rofecoxib therapy on measures of health-related quality of life in patients with osteoarthritis.
    Ehrich EW; Bolognese JA; Watson DJ; Kong SX
    Am J Manag Care; 2001 Jun; 7(6):609-16. PubMed ID: 11439734
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Multicenter randomized controlled trial to evaluate the effect of home-based exercise on patients with chronic low back pain: the Japan low back pain exercise therapy study.
    Shirado O; Doi T; Akai M; Hoshino Y; Fujino K; Hayashi K; Marui E; Iwaya T; ; ; ;
    Spine (Phila Pa 1976); 2010 Aug; 35(17):E811-9. PubMed ID: 20628332
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 30.